Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis

This study has been completed.
Information provided by:
Facet Biotech Identifier:
First received: April 22, 2005
Last updated: August 2, 2008
Last verified: August 2008